{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:09:10Z","timestamp":1794647350126,"version":"4.9.1"},"reference-count":37,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,11,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Lymphomas afflict all age groups of people, with certain types demonstrating a female predilection in adolescents and young adults. A proportion of lymphomas that are diagnosed in this population demographic occur in the setting of pregnancy. Most of these behave aggressively at presentation and require immediate or urgent therapy. Treatment must consider both maternal and fetal health, and management approaches are therefore influenced by gestational age at diagnosis and treatment and timing of delivery. Although there is a paucity of literature on how to treat these patients, limited retrospective reports demonstrate generally good outcomes and highlight the necessity of an experienced multidisciplinary team approach to management.<\/jats:p>","DOI":"10.1182\/blood.2019000961","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T18:58:29Z","timestamp":1597431509000},"page":"2118-2124","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":30,"title":["How I treat lymphoma in pregnancy"],"prefix":"10.1182","volume":"136","author":[{"given":"Kieron","family":"Dunleavy","sequence":"first","affiliation":[{"name":"Division of Hematology & Oncology, George Washington University Cancer Center, Washington, DC; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4771-8760","authenticated-orcid":false,"given":"Claire","family":"McLintock","sequence":"additional","affiliation":[{"name":"Women's HealthNB, Auckland City Hospital, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2020110511274701300_B1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.2009.23.2801","article-title":"Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes","volume":"28","author":"Van Calsteren","year":"2010","journal-title":"J Clin Oncol"},{"issue":"13","key":"2020110511274701300_B2","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/j.1471-0528.2012.03475.x","article-title":"Incidence and outcomes of pregnancy-associated cancer in Australia, 1994-2008: a population-based linkage study","volume":"119","author":"Lee","year":"2012","journal-title":"BJOG"},{"issue":"19","key":"2020110511274701300_B3","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1508913","article-title":"Pediatric outcome after maternal cancer diagnosed during pregnancy","volume":"373","author":"Amant","year":"2015","journal-title":"N Engl J Med"},{"issue":"9815","key":"2020110511274701300_B4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(11)61348-2","article-title":"Haematological cancers in pregnancy","volume":"379","author":"Brenner","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"2020110511274701300_B5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood-2018-02-778480","article-title":"Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspective","volume":"132","author":"Dunleavy","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2020110511274701300_B6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2214\/AJR.10.4271","article-title":"Body CT during pregnancy: utilization trends, examination indications, and fetal radiation doses","volume":"196","author":"Goldberg-Stein","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"2020110511274701300_B7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/1753495X19838658","article-title":"Diagnostic imaging in pregnancy: making informed decisions","volume":"12","author":"Lowe","year":"2019","journal-title":"Obstet Med"},{"issue":"11","key":"2020110511274701300_B8","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2967\/jnumed.117.195404","article-title":"New fetal radiation doses for 18F-FDG based on human data","volume":"58","author":"Zanotti-Fregonara","year":"2017","journal-title":"J Nucl Med"},{"issue":"1","key":"2020110511274701300_B9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.semnuclmed.2017.09.003","article-title":"PET\/CT for lymphoma post-therapy response assessment in hodgkin lymphoma and diffuse large B-cell lymphoma","volume":"48","author":"Kobe","year":"2018","journal-title":"Semin Nucl Med"},{"issue":"1","key":"2020110511274701300_B10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2016.01.004","article-title":"Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort","volume":"215","author":"Manuck","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2020110511274701300_B11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1182\/asheducation-2017.1.298","article-title":"Primary mediastinal B-cell lymphoma: biology and evolving therapeutic strategies","volume":"2017","author":"Dunleavy","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"2020110511274701300_B12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"issue":"22","key":"2020110511274701300_B13","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2018-05-851154","article-title":"Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens","volume":"132","author":"Mottok","year":"2018","journal-title":"Blood"},{"issue":"15","key":"2020110511274701300_B14","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"2020110511274701300_B15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/bjh.14951","article-title":"Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R","volume":"179","author":"Giulino-Roth","year":"2017","journal-title":"Br J Haematol"},{"issue":"21","key":"2020110511274701300_B16","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1200\/JCO.18.01994","article-title":"Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-cell lymphoma: clinical outcomes of the phase III Intergroup Trial Alliance\/CALGB 50303","volume":"37","author":"Bartlett","year":"2019","journal-title":"J Clin Oncol"},{"issue":"9","key":"2020110511274701300_B17","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3324\/haematol.11097","article-title":"The treatment of Hodgkin\u2019s and non-Hodgkin\u2019s lymphoma in pregnancy","volume":"92","author":"Pereg","year":"2007","journal-title":"Haematologica"},{"issue":"5","key":"2020110511274701300_B18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1470-2045(04)01466-4","article-title":"Use of chemotherapy during human pregnancy","volume":"5","author":"Cardonick","year":"2004","journal-title":"Lancet Oncol"},{"issue":"32","key":"2020110511274701300_B19","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1200\/JCO.2013.49.8220","article-title":"Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis","volume":"31","author":"Evens","year":"2013","journal-title":"J Clin Oncol"},{"issue":"8","key":"2020110511274701300_B20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/jamaoncol.2016.1396","article-title":"Maternal and fetal outcomes after therapy for Hodgkin or Non-Hodgkin lymphoma diagnosed during pregnancy","volume":"2","author":"Pinnix","year":"2016","journal-title":"JAMA Oncol"},{"issue":"3","key":"2020110511274701300_B21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11899-013-0163-4","article-title":"Hodgkin lymphoma in pregnancy","volume":"8","author":"Bachanova","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"issue":"11","key":"2020110511274701300_B22","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/S2352-3026(19)30195-4","article-title":"Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study","volume":"6","author":"Maggen","year":"2019","journal-title":"Lancet Haematol"},{"issue":"3","key":"2020110511274701300_B23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11899-017-0386-x","article-title":"The management of lymphoma in the setting of pregnancy","volume":"12","author":"Pinnix","year":"2017","journal-title":"Curr Hematol Malig Rep"},{"issue":"5","key":"2020110511274701300_B24","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.2017.75.2543","article-title":"Early chemotherapy intensification with escalated BEACOPP in patients with advanced-stage Hodgkin lymphoma with a positive interim positron emission tomography\/computed tomography scan after two ABVD cycles: long-term results of the GITIL\/FIL HD 0607 trial","volume":"36","author":"Gallamini","year":"2018","journal-title":"J Clin Oncol"},{"issue":"4","key":"2020110511274701300_B25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1056\/NEJMoa1708984","article-title":"Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin\u2019s lymphoma","volume":"378","author":"Connors","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"2020110511274701300_B26","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1158\/1078-0432.CCR-18-2435","article-title":"Brentuximab vedotin plus chemotherapy in North American subjects with newly diagnosed stage III or IV Hodgkin lymphoma","volume":"25","author":"Ramchandren","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2020110511274701300_B27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood-2018-01-827246","article-title":"CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET","volume":"132","author":"Straus","year":"2018","journal-title":"Blood"},{"issue":"12","key":"2020110511274701300_B28","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1182\/blood-2015-11-679407","article-title":"PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study","volume":"127","author":"Barrington","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2020110511274701300_B29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0167-8140(02)00329-8","article-title":"Radiotherapy of Hodgkin\u2019s disease in early pregnancy: embryo dose measurements","volume":"66","author":"Mazonakis","year":"2003","journal-title":"Radiother Oncol"},{"key":"2020110511274701300_B30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2014.11.009","article-title":"Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease","volume":"57","author":"Roberts","year":"2015","journal-title":"J Autoimmun"},{"issue":"4","key":"2020110511274701300_B31","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V81.4.916.916","article-title":"Granulocyte colony-stimulating factor crosses the placenta and stimulates fetal rat granulopoiesis","volume":"81","author":"Medlock","year":"1993","journal-title":"Blood"},{"issue":"1","key":"2020110511274701300_B32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/AOG.0000000000000602","article-title":"Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia","volume":"125","author":"Boxer","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"22","key":"2020110511274701300_B33","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"issue":"19","key":"2020110511274701300_B34","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: ASCO clinical practice guideline update","volume":"36","author":"Oktay","year":"2018","journal-title":"J Clin Oncol"},{"issue":"6","key":"2020110511274701300_B35","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2214\/AJR.12.9720","article-title":"CT radiation dose: current controversies and dose reduction strategies","volume":"201","author":"Costello","year":"2013","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"2020110511274701300_B36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1148\/rg.293085226","article-title":"Quality initiatives: imaging pregnant patients with suspected pulmonary embolism: what the radiologist needs to know","volume":"29","author":"Pahade","year":"2009","journal-title":"Radiographics"},{"issue":"6","key":"2020110511274701300_B37","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1148\/rg.2015150031","article-title":"Imaging pregnant and lactating patients","volume":"35","author":"Tirada","year":"2015","journal-title":"Radiographics"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/19\/2118\/1780344\/bloodbld2019000961c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/19\/2118\/1780344\/bloodbld2019000961c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T16:28:11Z","timestamp":1604593691000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/136\/19\/2118\/463256\/How-I-treat-lymphoma-in-pregnancy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":37,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2020,11,5]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019000961","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]}}}